Milner Therapeutics Symposium 2018
The Milner Therapeutics Symposium
This Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner Therapeutics Institute alliance partners.
Academic poster presentations are available at the Symposium. Please submit an abstract of no more than 200 words to email@example.com. Abstract submission deadline Monday 17th September.
If you would like to attend the Symposium but your company is not affiliated with the Milner Therapeutics Institute please email firstname.lastname@example.org before registration.
Gordon Dougan, Wellcome Trust Sanger Institute
Declan Jones, J&J London Innovation Centre
Jane Osborne, MedImmune
Stephen O’Rahilly, Metabolic Research Laboratories, University of Cambridge
Emma Rawlins, Gurdon Institute, University of Cambridge
Paul Workman, The Institute of Cancer Research, London